Andrulis IL - Search Results

1

Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish women.

Apicella C, Dowty JG, Dite GS, Jenkins MA, Senie RT, Daly MB, Andrulis IL, John EM, Buys SS, Li FP, Glendon G, Chung W, Ozcelik H, Miron A, Kotar K, Southey MC, Foulkes WD, Hopper JL. Apicella C, et al. Among authors: andrulis il. Clin Genet. 2007 Aug;72(2):87-97. doi: 10.1111/j.1399-0004.2007.00841.x. Clin Genet. 2007. PMID: 17661812

2

Multiplex PCR-SSCP for simultaneous screening for mutations in several exons of p53.

Ozçelik H, Andrulis IL. Ozçelik H, et al. Among authors: andrulis il. Biotechniques. 1995 May;18(5):742-4. Biotechniques. 1995. PMID: 7619467 No abstract available.

3

Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer.

Mousses S, Ozçelik H, Lee PD, Malkin D, Bull SB, Andrulis IL. Mousses S, et al. Among authors: andrulis il. Hum Mol Genet. 1995 Jun;4(6):1089-92. doi: 10.1093/hmg/4.6.1089. Hum Mol Genet. 1995. PMID: 7655464

4

Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation.

Ozcelik H, Antebi YJ, Cole DE, Andrulis IL. Ozcelik H, et al. Among authors: andrulis il. Hum Genet. 1996 Sep;98(3):310-2. doi: 10.1007/s004390050212. Hum Genet. 1996. PMID: 8707299

5

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients.

Ozçelik H, Schmocker B, Di Nicola N, Shi XH, Langer B, Moore M, Taylor BR, Narod SA, Darlington G, Andrulis IL, Gallinger S, Redston M. Ozçelik H, et al. Among authors: andrulis il. Nat Genet. 1997 May;16(1):17-8. doi: 10.1038/ng0597-17. Nat Genet. 1997. PMID: 9140390 No abstract available.

6

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.

Done SJ, Arneson NC, Ozçelik H, Redston M, Andrulis IL. Done SJ, et al. Among authors: andrulis il. Cancer Res. 1998 Feb 15;58(4):785-9. Cancer Res. 1998. PMID: 9485035

7

Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers.

Ozçelik H, To MD, Couture J, Bull SB, Andrulis IL. Ozçelik H, et al. Among authors: andrulis il. Int J Cancer. 1998 Jul 3;77(1):1-6. doi: 10.1002/(sici)1097-0215(19980703)77:1<1::aid-ijc1>3.0.co;2-y. Int J Cancer. 1998. PMID: 9639385 Free article.

8

Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations.

Ozçelik H, Mousses S, Andrulis IL. Ozçelik H, et al. Among authors: andrulis il. Clin Cancer Res. 1995 Aug;1(8):907-12. Clin Cancer Res. 1995. PMID: 9816061

9

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations.

Phillips KA, Nichol K, Ozcelik H, Knight J, Done SJ, Goodwin PJ, Andrulis IL. Phillips KA, et al. Among authors: andrulis il. J Natl Cancer Inst. 1999 Mar 3;91(5):469-73. doi: 10.1093/jnci/91.5.469. J Natl Cancer Inst. 1999. PMID: 10070948

10

Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer.

Khoo US, Ozcelik H, Cheung AN, Chow LW, Ngan HY, Done SJ, Liang AC, Chan VW, Au GK, Ng WF, Poon CS, Leung YF, Loong F, Ip P, Chan GS, Andrulis IL, Lu J, Ho FC. Khoo US, et al. Among authors: andrulis il. Oncogene. 1999 Aug 12;18(32):4643-6. doi: 10.1038/sj.onc.1202847. Oncogene. 1999. PMID: 10467410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

471 results

Search Page